CEP164 p.Pro495fs
c.1481dup · rs752518735 · VCV1009382
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | frameshift | predicted loss-of-function |
|---|---|---|
| NMD | predicted | premature termination codon in exon 13 of 33 |
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
| Constraint at this position | ||
| Conservation | phyloP 2.5 | GERP -0.84, phastCons 0.99 |
| Overall | ||
| CADD | 22.4 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.0271% | 3,696 |
| East Asiangrpmax | 0.00899% | 11,117 |
| Admixed American | 0.0051% | 19,613 |
| Remaining individualsnot grpmax-eligible | 0.00161% | 61,984 |
| African / African-American | 0.00134% | 74,654 |
| European (non-Finnish) | 0.00119% | 83,912 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CEP164
- Protein
- p.Pro495fs
- Coding
- c.1481dup
- MANE Select
- NM_014956
- dbSNP
- rs752518735
- Type
- Duplication
- Location
- chr11:117381770 (GRCh38)
- Gene constraint
- LOEUF 1.009 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 63.08 · 4 PDB
- Residue 495
- the 'disordered' region
Disease context
nephronophthisis 15 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Senior-Loken syndrome (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Childhood, Infancy
- Prevalence
- 1-9 / 1 000 000 (Worldwide)
Similar variants
- CEP164 p.Pro495Arg Benign/Likely benign ★★ same residue
- CEP164 p.Pro495Thr Uncertain significance ★ ⚠ same residue
- CEP164 p.Gln1014fs Pathogenic/Likely pathogenic ★★ same condition
- CEP164 p.Glu557fs Pathogenic/Likely pathogenic ★★ same condition
- CEP164 p.Glu846fs Pathogenic/Likely pathogenic ★★ same condition
- CEP164 p.Gly250_Asp251insTer Pathogenic/Likely pathogenic ★★ same condition
- CEP164 p.Lys113fs Pathogenic/Likely pathogenic ★★ same condition
- CEP164 p.Lys128fs Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cep164-p-pro495fs (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown